Cardiff Oncology
CRDF
26 hedge funds and large institutions have $20.3M invested in Cardiff Oncology in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4% more funds holding
Funds holding: 25 → 26 (+1)
23% less capital invested
Capital invested by funds: $26.4M → $20.3M (-$6.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$164K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$124K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$79.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.95M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$412K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$293K |
| 4 |
FNYS
First New York Securities
New York
|
-$266K |
| 5 |
BIA
Biondo Investment Advisors
Milford,
Pennsylvania
|
-$215K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EI
26
EAM Investors
Solana Beach,
California
| – | -$1.95M | -3,765 | Closed |
|
|
RFC
27
Russell Frank Company
Seattle,
Washington
| – | -$412K | -796 | Closed |
|
|
FNYS
28
First New York Securities
New York
| – | -$266K | -515 | Closed |
|
|
BIA
29
Biondo Investment Advisors
Milford,
Pennsylvania
| – | -$215K | -417 | Closed |
|
30
Millennium Management
New York
| – | -$141K | -273 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$1.78K | -4 | -80% |
|
CRDF Hedge Fund Activity: Q4 2013 in Review
26 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2013, worth a combined $20.3M — down 23% from $26.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CRDF positions and 6 closed out — a net gain of 1 holder — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Cambridge Investment Research Advisors, adding an estimated $164K. The largest seller was EAM Investors, exiting entirely with an estimated $1.95M sold.
- 26 institutional investors held Cardiff Oncology (CRDF) as of Q4 2013, up from 25 in Q3 2013.
- Funds reported $20.3M of Cardiff Oncology stock for Q4 2013, down 23% quarter-over-quarter.
- 7 funds opened new Cardiff Oncology positions in Q4 2013 and 6 closed out, a net change of +1 holder.
- The largest Cardiff Oncology buyer in Q4 2013 was Cambridge Investment Research Advisors, an estimated $164K added.
- The largest Cardiff Oncology seller in Q4 2013 was EAM Investors, an estimated $1.95M sold.
Based on aggregated 13F filings for Q4 2013.